Balcoltra is a combined oral contraceptive (COC), or birth control. It contains 3 medications: levonorgestrel (a progestin), ethinyl estradiol (an estrogen), and ferrous bisglycinate (an iron supplement). Balcoltra is taken by mouth once daily. Each 28-day pack of Balcoltra contains 21 active (hormone) pills and 7 placebo pills. Balcoltra is a monophasic birth control, meaning each active pill contain the same amount of hormones. Some side effects of this COC include headache, abnormal bleeding, and period cramping. Balcoltra is available as a generic called Joyeaux.
To prevent pregnancy
Balcoltra is a combination of two hormones, levonorgestrel (a progestin) and ethinyl estradiol (an estrogen). These two hormones work together to help prevent pregnancy by:
Stopping ovulation (release of an egg from the ovary)
Thickening cervical mucus (fluid from the cervix), which makes it hard for sperm to move and fertilize an egg
Thinning the lining of the uterus (womb) so a fertilized egg can't implant
Balcoltra also contains ferrous bisglycinate, an iron supplement.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Taken by mouth
Taken once daily
Placebo (hormone-free) pills contain an iron supplement
Available as a generic
Doesn't protect against sexually transmitted diseases (STDs)
Can cause unpleasant side effects, like headache and abnormal bleeding
Can't be used by females over 35 who smoke because of risk of blood clots
Not appropriate for people allergic to FD&C Yellow No. 5 (tartrazine)
Balcoltra can prevent pregnancy, but it can't protect you from human immunodeficiency virus (HIV), hepatitis, or other sexually transmitted diseases (STDs). Using a condom along with Balcoltra can help lower your risk of an STD.
Balcoltra isn't an emergency contraception (morning-after pill) and shouldn't be used after unprotected sex to prevent pregnancy. Talk to your gynecologist or pharmacist if you had unprotected sex and need an emergency contraception, such as levonorgestrel (Plan B One-Step) or Ella (ulipristal).
Try to take Balcoltra around the same time every day. Consider setting an alarm to remind yourself to take your doses at the scheduled time.
If you missed one active Balcoltra tablet, take your missed dose as soon as possible. Then, take your next scheduled dose at the regular time. You might need to take two tablets in one day. If you've missed more than one tablet in a blister pack, refer to the instructions that came with your pack or call your gynecologist or pharmacist for further instructions.
You might experience irregular bleeding while taking Balcoltra. For some people, this means having heavier periods. But for others, this could mean missing periods or having breakthrough bleeding. Continue to take Balcoltra every day as directed by your gynecologist. Speak with your gynecologist if you're concerned about changes in your period.
Let your gynecologist know if you experience symptoms of depression or worsening mood while taking Balcoltra. In cases of serious depression, your gynecologist might ask you to stop taking this medication.
If you've had a skin condition that causes brownish patches on your skin, these patches can reappear or darken while taking Balcoltra. Avoid exposing your skin to the sun or ultraviolet radiation (e.g., tanning booths, sun lamps) while you're taking this medication.
Let your healthcare team know if you're scheduled to have surgery while taking Balcoltra. Because taking COCs can raise your risk of blood clots after surgery, your healthcare team will likely ask you to stop taking Balcoltra at least a month before your surgery, and not restart treatment until at least 2 weeks after your surgery.
Get immediate medical attention if you notice symptoms of a blood clot, including trouble catching your breath, leg pain that won't go away, or sudden and severe headache. Though rare, taking COCs, including Balcoltra, can raise the risk for blood clots.
Call 911 if you experience sudden swelling around the face, lips, or throat that makes it hard for you to breathe. Though rare, Balcoltra and other birth control pills can trigger a reaction called angioedema, especially in people who've had similar reactions in the past.
Balcoltra can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Females over 35 years old who smoke cigarettes
Smoking cigarettes while taking COCs, like Balcoltra, can significantly raise the risk of serious heart problems, including heart attack and stroke. The risk is greater if you're over 35 years old. If you smoke, talk with your gynecologist about safer birth control alternatives.
Risk factors: Females over 35 years old who smoke | Females over 40 years old who don't smoke | Recent surgery with a long period of bed rest | Starting COCs less than a month after childbirth | High blood pressure | People identified as obese | High cholesterol | Diabetes | Higher dose of estrogen | First year of using COCs | Restarting COCs after a month
Balcoltra can raise the risk of serious blood clots because it contains ethinyl estradiol (an estrogen). More estrogen can lead to more blood proteins that stimulate clot formation. These blood clots can be life-threatening and can happen anywhere in your body. Get medical attention right away if you have any signs or symptoms of a blood clot:
Brain (e.g., stroke): weakness or numbness in your arms, legs, or face on one side of the body, trouble speaking, blurry vision, dizziness, loss of balance, trouble walking, or confusion
Eyes (e.g., retinal thrombosis): trouble seeing, bulging eye, double vision
Heart (e.g., heart attack): chest pain, sweating, nausea, or dizziness
Lungs (e.g., pulmonary embolism or PE): trouble breathing, chest pain, or cough
Legs (e.g., deep vein thrombosis or DVT): cramps, swelling, pain, or muscle tightness
Your risk of getting a blood clot is higher if you're older, smoke cigarettes, or have certain medical conditions. Your risk is also higher if you're on bedrest after surgery or if you've just given birth. Typically your gynecologist will temporarily stop Balcoltra for 3-4 weeks before surgery, then restart it 2 weeks after. If you recently delivered a baby, you shouldn't start this medication until 4 weeks after delivery and if you're not breastfeeding. Talk with your gynecologist if you have any questions regarding your risk of blood clots.
Risk factors: History of breast or cervical cancer | Taking COCs for a long time | Taken COCs in the last 6 months
It's not clear whether Balcoltra and other COCs can significantly raise your risk for breast and cervical cancer. Research shows that people who used COCs for more than 5 years seemed to be at a greater risk for cervical cancer than those who never used these medications. In addition, certain breast cancer cells grow faster in the presence of estrogen. Since there's a risk of serious harm, don't take Balcoltra if you currently have or have had breast cancer or cervical cancer. If you currently take this medication or have taken it in the last 6 months, make sure to get a yearly breast exam with your gynecologist to check for early signs of breast cancer. Your gynecologist can also make sure you get appropriate screenings for cervical cancer. Let your gynecologist know if you notice any signs of breast cancer (e.g., new or abnormal lumps, pain, or swelling in your breasts) or cervical cancer (e.g., vaginal bleeding or discharge that's not normal).
Risk factors: Taking COCs for more than 8 years | Certain hepatitis C medications
Don't take Balcoltra if you have liver problems, such as liver infection caused by a virus (e.g., hepatitis), cirrhosis (scarring of the liver) or liver tumors. Although rare, this medication can raise your risk of getting benign liver tumors. If you experience signs of liver problems, you should stop taking Balcoltra and ask your gynecologist for an alternative birth control. Signs of liver problems can include jaundice (yellowing of the skin or whites of the eyes), fever, tiredness, loss of appetite, or dark colored urine.
Additionally, Balcoltra shouldn’t be taken together with Viekira Pak, a hepatitis C medication contains ombitasvir, paritaprevir, and ritonavir. Doing so can cause liver problems. You can restart Balcoltra two weeks after completing hepatitis C treatment.
Some studies suggest that Balcoltra can raise the risk of gallbladder disease since more progestin and estrogen can lead to higher chance of gallstones. Although the risk is low, talk to your gynecologist if you a history of gallbladder disease before starting Balcoltra.
Risk factors: High blood sugar | High triglycerides
Balcoltra can raise your levels of blood sugar and triglycerides (a type of fat). Your risk is higher if you already have high blood sugar levels. This is because Balcoltra can prevent your body from breaking down sugar properly.
Additionally, this medication can raise your triglycerides levels and put you at risk for pancreatitis (pancreas inflammation). Speak with your gynecologist before starting Balcoltra if you have a history of high blood sugar or triglycerides. Your gynecologist might help you choose another birth control or monitor your blood work more closely if you take this medication.
Risk factors: Older age | Using COCs for a long time | History of high blood pressure | Kidney problems
Balcoltra can raise your blood pressure, so make sure you check your blood pressure while you're taking this medication. The risk is higher if you're older and have been taking birth control for a long period of time. If you have a history of kidney problems or high blood pressure that's not controlled, don't use this medication. Talk with your gynecologist so you can discuss the benefits and risks of taking Balcoltra.
Let your gynecologist know if you experience new or worsening migraines or headaches while taking Balcoltra. You might need to stop your medication if your migraine or headache doesn't go away or becomes severe.
Risk factor: First 3 months of COCs
People who take Balcoltra can sometimes experience irregular bleeding and spotting, especially during the first 3 months of taking this medication. Irregular bleeding can vary from slight staining to bleeding similar to a regular period. This problem is often temporary, so continue taking your medication as directed. If your bleeding doesn't stop, becomes heavier, or you miss a period after the initial bleeding, let your gynecologist know. Your gynecologist can perform blood tests to rule out other potential causes for bleeding.
Some medications can interfere with how your body gets rid of Balcoltra. This can affect the amount of Balcoltra in your body, how well it works, and the risk of side effects.
Taking medications like rosuvastatin (Crestor) or atorvastatin (Lipitor) can raise the amount of Balcoltra in your body, which can cause a higher risk of side effects.
Taking medications like carbamazepine (Tegretol) or topiramate can lower the amount of Balcoltra in your body. This can cause your birth control to not work as well. Use a condom when you take these medications together and for 28 days after stopping carbamazepine (Tegretol) or topiramate.
Balcoltra also interferes with how your body gets rid of other medications. For example, it shouldn’t be taken with lamotrigine (Lamictal). Doing so can drop levels of lamotrigine (Lamictal) in your body and raise your risk for seizures or mood changes.
If you take Balcoltra and a medication to replace your thyroid hormone, such as levothyroxine (Synthroid), you might need to take a higher dose of your thyroid medication since Balcoltra can cause it to not work as well.
Let your gynecologist or pharmacist know what other medications you’re taking before and while taking Balcoltra.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
28 tablets of 0.1mg/0.02mg/36.5mg | 1 package | $271.83 | $271.83 |
Balcoltra comes in a 28-day pack, which contains 21 active (hormone) tablets and 7 placebo tablets. Each active tablet contains 0.1 mg levonorgestrel and 20 mcg ethinyl estradiol. Each placebo tablet contains 36.5 mg ferrous bisglycinate.
Make sure to take your medication as instructed by your gynecologist or follow the directions on the package. In general, the typical dose is to take 1 active tablet by mouth daily for 21 days, followed by 1 placebo tablet daily for the remaining 7 days.
History of blood clots, stroke, or heart attack
Females over the age of 35 who smoke or have migraine headaches
Certain medical conditions like uncontrolled high blood pressure, diabetes, obesity, coronary artery disease (CAD), or atrial fibrillation (AFib)
Liver tumors or liver disease
Currently pregnant
Currently have or have had breast cancer
Abnormal vaginal bleeding that your gynecologist doesn’t know about or you haven’t gone to them about
Take certain hepatitis C medications like Viekira Pak, containing ombitasvir, paritaprevir, and ritonavir; with or without dasabuvir
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
American College of Obstetricians and Gynecologists. (2023). Abnormal uterine bleeding.
American College of Obstetricians and Gynecologists. (2023). Effectiveness of birth control methods.
Avion Pharmaceuticals. (2022). Balcoltra- levonorgestrel and ethinyl estradiol [package insert]. DailyMed.
Avion Pharmaceuticals. (2023). Balcoltra- levonorgestrel and ethinyl estradiol kit [package insert]. DailyMed.
Centers for Disease Control and Prevention. (n.d.). Sexually transmitted infections (STIs).
Centers for Disease Control and Prevention. (2024). About HIV.
Centers for Disease Control and Prevention. (2024). Viral hepatitis among sexually active adults.
Etminan, M., et al. (2011). Oral contraceptives and the risk of gallbladder disease: a comparative safety study. Canadian Medical Association Journal.
Fischer, J. A. J., et al. (2021). Iron-containing oral contraceptives and their effect on hemoglobin and biomarkers of iron status: A narrative review. Nutrients.
International Agency for Research on Cancer. (2012). Combined estrogen-progestogen contraceptives. Pharmaceuticals.
Latwal, B., et al. (2020). Authorized generics vs. branded generics: A perspective. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector.
National Cancer Institute. (2018). Oral contraceptives and cancer risk.
National Institute of Diabetes and Digestive and Kidney Disease. (2017). Gallstones.
Rehak, M., et al. (2010). Retinal vein thrombosis: Pathogenesis and management. Journal of Thrombosis and Haemostasis.
Xiromed, LLC. (2024). Joyeaux- levonorgestrel and ethinyl estradiol and ferrous fumarate [package insert]. DailyMed.
Xiromed, LLC. (2024). Joyeaux- levonorgestrel and ethinyl estradiol and ferrous fumarate kit [package insert]. DailyMed.
Xiromed LLC. (2023). Xiromed LLC announces launch of first-to-market generic version of Balcoltra® in the U.S.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.